Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gil Aizik, Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jbara-Agbaria D, Blondzik S, Burger-Kentischer A, Agbaria M, Nordling-David MM, Giterman A, Aizik G, Rupp S, Golomb G. Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies. Pharmaceutics. 2022 Mar 13; 14(3). PMID: 35336008; PMCID: PMC8948811.
  2. Aizik G, Waiskopf N, Agbaria M, Ben-David-Naim M, Nordling-David MM, Jbara-Agbaria D, Banin U, Golomb G. Targeting and imaging of monocyte-derived macrophages in rat's injured artery following local delivery of liposomal quantum dots. J Control Release. 2020 02; 318:145-157. PMID: 31830540.
    Citations:    Fields:    Translation:AnimalsCells
  3. Aizik G, Waiskopf N, Agbaria M, Ben-David-Naim M, Levi-Kalisman Y, Shahar A, Banin U, Golomb G. Liposomes of Quantum Dots Configured for Passive and Active Delivery to Tumor Tissue. Nano Lett. 2019 09 11; 19(9):5844-5852. PMID: 31424944.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  4. Ben-David-Naim M, Dagan A, Grad E, Aizik G, Nordling-David MM, Morss Clyne A, Granot Z, Golomb G. Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy. Cancers (Basel). 2019 Mar 29; 11(4). PMID: 30934857; PMCID: PMC6521050.
    Citations: 4     
  5. Aizik G, Grad E, Golomb G. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases. Drug Deliv Transl Res. 2018 Aug; 8(4):868-882. PMID: 29058205.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  6. Ben David-Naim M, Grad E, Aizik G, Nordling-David MM, Moshel O, Granot Z, Golomb G. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Biomaterials. 2017 Nov; 145:154-167. PMID: 28863309.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  7. Aizik G, Waiskopf N, Agbaria M, Levi-Kalisman Y, Banin U, Golomb G. Delivery of Liposomal Quantum Dots via Monocytes for Imaging of Inflamed Tissue. ACS Nano. 2017 03 28; 11(3):3038-3051. PMID: 28196324.
    Citations: 7     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Aizik's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (53)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.